Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study
Listen to this summary
The authors aimed to compare the real-world effectiveness and safety of tirzepatide and semaglutide for weight loss in patients with obesity, including those with prior obesity medication use. The study found that tirzepatide led to significantly greater weight loss than semaglutide over 12 months, with fewer gastrointestinal side effects reported. These findings suggest that tirzepatide may be a more effective option for weight management in this population, though further research in diverse groups is needed.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Mayo Clinic proceedings
View all →Jul 11, 2026 · Mayo Clinic proceedings
Embedding Ethics Into Decision-Making Capacity Assessment:An EHR-Enabled Systemwide Approach
Jul 4, 2026 · Mayo Clinic proceedings
Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study
Jul 2, 2026 · Mayo Clinic proceedings
Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice
Jul 2, 2026 · Mayo Clinic proceedings
Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety
Jul 1, 2026 · Mayo Clinic proceedings
Total and Premature Mortality in Single-Person Households: Comparative Study of Korean and UK Data
Jul 1, 2026 · Mayo Clinic proceedings
Selva Leaves by Ed Branson
More in Internal Medicine
View all →Jul 11, 2026 · American heart journal
Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysis
Jul 11, 2026 · Journal of hepatology
Surveillance of patients at risk of liver cancer: Expert opinions
Jul 11, 2026 · American heart journal
Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022)
Jul 11, 2026 · Journal of addiction medicine
Multiple Substance Use Disorders From Adolescence to Midlife
Jul 11, 2026 · American heart journal
Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study
Jul 11, 2026 · Journal of cardiac failure
An abbreviated exercise right heart catheterization protocol for the diagnosis of heart failure with preserved ejection fraction
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


